SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-20-000651
Filing Date
2020-02-14
Accepted
2020-02-14 12:00:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 orbimed-fomx123119a1.htm SC 13G/A 84787
  Complete submission text file 0001172661-20-000651.txt   86421
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED CAPITAL LLC (Filed by) CIK: 0001157524 (see all company filings)

IRS No.: 134133323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Subject) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88525 | Film No.: 20616305
SIC: 2833 Medicinal Chemicals & Botanical Products